newsfilter
← Latest News
GlobeNewswire·

FDA Approves XBiotech's IND in Rheumatology

AUSTIN, Texas, Dec. 13, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) today reports that the FDA's Division of Rheumatology has authorized the Company to commence clinical development of Natrunix, the Company's novel True Human™ antibody cand